SURG vs BJDX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 14, 2026

SURG

45.2
AI Score
VS
SURG Wins

BJDX

44.7
AI Score

Investment Advisor Scores

SURG

45score
Recommendation
HOLD

BJDX

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SURG BJDX Winner
Forward P/E 15.1515 0 Tie
PEG Ratio 0.5333 0 Tie
Revenue Growth 40.7% 0.0% SURG
Earnings Growth -77.7% 0.0% BJDX
Tradestie Score 45.2/100 44.7/100 SURG
Profit Margin -47.9% 0.0% BJDX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SURG 1M: -11.7% · 3M: -59.4% BJDX 1M: -4.1% · 3M: -46.3%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.7%), weak momentum, RSI 35

RSI (14): 35.0 · Price: $0.13

BJDX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.2%), weak momentum, RSI 40

RSI (14): 40.3 · Price: $0.78

Fundamentals Snapshot

Metric SURG BJDX
Market Cap — —
Forward P/E 12.7 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.4% 0.0%
Gross Margin -0.2% —
Operating Margin 0.2% 0.0%
EPS -1.50 -3.42
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.